Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017060

« Back to Dashboard

NDA 017060 describes NOR-QD, which is a drug marketed by Apil and is included in one NDA. It is available from one supplier. Additional details are available on the NOR-QD profile page.

The generic ingredient in NOR-QD is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 017060
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017060
Suppliers and Packaging for NDA: 017060
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOR-QD norethindrone TABLET;ORAL-28 017060 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 52544-629 52544-629-28 6 PACKAGE in 1 CARTON (52544-629-28) > 28 TABLET in 1 PACKAGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.35MG
Approval Date:Approved Prior to Jan 1, 1982TE:AB1RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.